Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A

Medivation Inc., which has already quadrupled in a year, is still tempting acquirers with a prostate cancer treatment that’s poised to make it one of the world’s fastest-growing drug developers.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.